McClure Matthew W.
Insider CIK 1927121 · ALGS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 72,000 | — | $0 | 72,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 75,183 | — | $0 | 75,183 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 16,428 | — | $0 | 16,428 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 65,713 | — | $0 | 65,713 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 92,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 23,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 255,626 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-09-08 | 2023-09-12 | 48,000 | — | $0 | 48,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-07-07 | 2022-07-11 | 46,000 | — | $0 | 46,000 | SEC↗ |